Overview

Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine

Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to confirm the safety and effectiveness of SB-01 For Injection in adult patients with chronic low back pain and related disability due to Lumbar Degenerative Disc Disease. The primary effectiveness hypothesis is superiority of the investigational product relative to control in terms of the percentage of subjects improving in pain-related disability.
Phase:
Phase 3
Details
Lead Sponsor:
Spine BioPharma, Inc
Collaborator:
MCRA, LLC